Citadel Advisors
CDNA icon

Citadel Advisors’s CareDx CDNA Stock Holding History

Citadel Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,900
Closed -$173K – 12767
2025
Q3 		$173K Buy
+11,900
New +$170K ﹤0.01% 11409
2025
Q2 		– Sell
-5,000
Closed -$88.8K – 12737
2025
Q1 		$88.8K Sell
5,000
-800
-14% -$17.2K ﹤0.01% 11634
2024
Q4 		$124K Sell
5,800
-4,100
-41% -$99.7K ﹤0.01% 11139
2024
Q3 		$309K Sell
9,900
-100
-1% -$2.49K ﹤0.01% 9284
2024
Q2 		$155K Buy
10,000
+2,100
+27% +$25.4K ﹤0.01% 10301
2024
Q1 		$83.7K Buy
7,900
+5,400
+216% +$54K ﹤0.01% 11595
2023
Q4 		$30K Sell
2,500
-2,700
-52% -$22.1K ﹤0.01% 12265
2023
Q3 		$36.4K Sell
5,200
-6,100
-54% -$56.4K ﹤0.01% 12113
2023
Q2 		$96K Sell
11,300
-4,500
-28% -$37.5K ﹤0.01% 11004
2023
Q1 		$144K Sell
15,800
-12,300
-44% -$157K ﹤0.01% 10699
2022
Q4 		$321K Buy
+28,100
New +$416K ﹤0.01% 9169
2022
Q3 		– Sell
-13,400
Closed -$288K – 12689
2022
Q2 		$288K Hold
13,400
– – ﹤0.01% 9896
2022
Q1 		$496K Sell
13,400
-17,500
-57% -$682K ﹤0.01% 9420
2021
Q4 		$1.41M Buy
30,900
+10,300
+50% +$538K ﹤0.01% 7042
2021
Q3 		$1.3M Buy
20,600
+6,300
+44% +$480K ﹤0.01% 7446
2021
Q2 		$1.31M Sell
14,300
-1,100
-7% -$87.4K ﹤0.01% 7650
2021
Q1 		$1.05M Buy
15,400
+9,800
+175% +$761K ﹤0.01% 7991
2020
Q4 		$406K Buy
+5,600
New +$324K ﹤0.01% 8538
2020
Q3 		– Sell
-9,900
Closed -$351K – 10115
2020
Q2 		$351K Sell
9,900
-2,500
-20% -$71.1K ﹤0.01% 7659
2020
Q1 		$271K Sell
12,400
-1,500
-11% -$33.6K ﹤0.01% 7507
2019
Q4 		$300K Buy
13,900
+1,800
+15% +$41.3K ﹤0.01% 7583
2019
Q3 		$274K Sell
12,100
-6,200
-34% -$172K ﹤0.01% 7685
2019
Q2 		$659K Buy
+18,300
New +$586K ﹤0.01% 6379

Other funds holding CDNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Citadel Advisors's CDNA Position: Q1 2026 in Review

Citadel Advisors reduced its CareDx (CDNA) stake by 87% in Q1 2026, selling an estimated $10.6M and leaving 84,173 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #6773.

Citadel Advisors first reported a position in CDNA in Q1 2018 and has held it in 30 quarters since. The position peaked at $24.7M in Q3 2021. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Citadel Advisors held 84,173 shares of CareDx worth $1.46M as of Q1 2026.
  • Citadel Advisors sold 558,589 CareDx shares in Q1 2026, an estimated $10.6M.
  • CareDx made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6773 holding.
  • Citadel Advisors first reported a position in CareDx in Q1 2018 and has held it in 30 quarters since.
  • Citadel Advisors's CareDx position peaked at $24.7M in Q3 2021.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.